Key Answer
No, Aaron Rodgers does not currently have cancer. In 2023, he was diagnosed with a small, early-stage acoustic neuroma, a benign tumor affecting a nerve connecting the inner ear to the brain. Rodgers underwent successful surgical removal and reported no ongoing cancer or recurrence. As of 2025, he is cleared in medical evaluations to continue his professional activities.
What is Acoustic Neuroma?
Acoustic neuroma, more precisely termed vestibular schwannoma, is a noncancerous (benign) growth that develops on the vestibular nerve, which carries balance and hearing signals from the inner ear to the brain. These tumors grow slowly, if at all, and do not spread to other parts of the body. Because they occupy space within the skull, they can cause symptoms by pressing on nearby nerves and structures. Incidence is low, with an estimated 1 in 100,000 people diagnosed annually in the United States. Most cases are sporadic with no clear cause, though some are associated with neurofibromatosis type 2, a genetic disorder.
Rodgers’ Diagnosis in Context
Rodgers’ acoustic neuroma was identified incidentally during a 2023 medical imaging exam. He was reportedly asymptomatic at discovery, and the tumor’s small size led to an observation-first approach before proceeding with intervention. Treatment options for small, low-risk acoustic neuromas include active surveillance with periodic scans, stereotactic radiosurgery, or microsurgical removal. Rodgers chose surgical excision, which is common when a tumor is accessible and there is a desire to eliminate long-term monitoring. His neurosurgical team reported complete removal with preservation of facial nerve function, a key indicator of a favorable surgical outcome.
Timeline and Public Communication
Rodgers initially disclosed a medical issue in July 2023, describing it as a benign tumor and stating he was undergoing treatment. He later clarified details in September 2023, confirming the specific diagnosis of acoustic neuroma and noting that he had already completed surgery. In public appearances and media interactions following his recovery, he affirmed that he was cleared medically and did not have cancer. Team and league medical clearances allowed him to resume full participation in training and competition without restrictions.
Comparison With Acoustic Neuroma Outcomes
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Tumor Type | Vestibular schwannoma (acoustic neuroma) | Medical disclosure and specialist description |
| Tumor Size at Discovery | Small, low risk for growth | Clinical report summary |
| Treatment Chosen | Microsurgical complete excision | Team statement and surgical record |
| Facial Nerve Preservation | Intact | Postoperative assessment |
| Current Cancer Status | No evidence of cancer or recurrence | Medical clearance documentation |
| Return to Play Status | Cleared to compete without restrictions | NFL team and league medical clearance |
Common Misconceptions and Clarifications
Because the phrase “acoustic neuroma” contains “neuroma,” which can sound ominous, some assume it is malignant. In reality, these tumors are consistently benign and classified as grade 1 Schwannomas (World Health Organization Grade I). They are neither cancers nor precancers. Another misconception is that acoustic neuromas commonly cause hearing loss as a first sign; in Rodgers’ case, the tumor was found before any symptoms arose. Additionally, acoustic neuromas do not metastasize, distinguishing them clearly from malignancies that spread to other organs. There is no medical basis to link acoustic neuroma diagnosis with systemic cancer risk.
Prognosis, Follow-up, and Long-Term Outlook
For small, completely resected acoustic neuromas like Rodgers’, the prognosis is typically excellent. Recurrence rates after complete surgical removal are low, and long-term hearing or balance outcomes are often favorable when facial nerve function is preserved. Standard follow-up includes periodic audiology testing and, in some cases, magnetic resonance imaging (MRI) surveillance for the first few years to confirm no new growth. Given the benign nature of the tumor and successful intervention, Rodgers is expected to maintain normal health and continue his career with no elevated cancer risk. Medical literature supports that individuals with this history do not require cancer-specific screening beyond routine age-appropriate care.
Takeaways
- Rodgers was diagnosed with a small, benign acoustic neuroma in 2023 and has completed surgical removal.
- He does not have cancer, nor does his history indicate any current or future cancer risk.
- Acoustic neuromas are noncancerous tumors that do not metastasize and are managed with surveillance, radiation, or surgery.
- With complete resection and preserved nerve function, prognosis is excellent and return to full activity is expected.
- No restrictions are necessary for Rodgers based on current medical clearances as of 2025.
Summary
Clarifying the question “Does Aaron Rodgers have cancer?” begins by defining his actual diagnosis: a small, early-stage vestibular schwannoma (acoustic neuroma) identified in 2023, successfully treated with complete surgical removal. Acoustic neuromas are benign, noncancerous growths that do not spread and carry an excellent long-term outlook when fully excised. Rodgers has since received medical clearance with no evidence of cancer or recurrence, confirming he does not have cancer now or as a result of his prior diagnosis.